MHR
Matthew Hamilton Rosenberg’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Sell |
3,716
-96
| -3% | -$6.63K | 0.06% | 171 |
|
|
2025
Q1 | $265K | Hold |
3,812
| – | – | 0.07% | 145 |
|
|
2024
Q4 | $328K | Hold |
3,812
| – | – | 0.09% | 112 |
|
|
2024
Q3 | $454K | Buy |
3,812
+94
| +3% | +$11.2K | 0.12% | 81 |
|
|
2024
Q2 | $541K | Sell |
3,718
-94
| -2% | -$13.7K | 0.16% | 68 |
|
|
2024
Q1 | $486K | Hold |
3,812
| – | – | 0.14% | 73 |
|
|
2023
Q4 | $394K | Sell |
3,812
-56
| -1% | -$5.79K | 0.12% | 86 |
|
|
2023
Q3 | $352K | Buy |
3,868
+1,934
| +100% | +$176K | 0.12% | 89 |
|
|
2023
Q2 | $313K | Buy |
1,934
+48
| +3% | +$7.77K | 0.11% | 106 |
|
|
2023
Q1 | $300K | Hold |
1,886
| – | – | 0.1% | 126 |
|
|
2022
Q4 | $255K | Buy |
1,886
+47
| +3% | +$6.36K | 0.09% | 145 |
|
|
2022
Q3 | $183K | Hold |
1,839
| – | – | 0.07% | 176 |
|
|
2022
Q2 | $205K | Sell |
1,839
-157
| -8% | -$17.5K | 0.08% | 163 |
|
|
2022
Q1 | $222K | Hold |
1,996
| – | – | 0.08% | 172 |
|
|
2021
Q4 | $224K | Hold |
1,996
| – | – | 0.08% | 167 |
|
|
2021
Q3 | $192K | Buy |
1,996
+700
| +54% | +$67.3K | 0.08% | 171 |
|
|
2021
Q2 | $109K | Hold |
1,296
| – | – | 0.06% | 242 |
|
|
2021
Q1 | $87K | Hold |
1,296
| – | – | 0.05% | 270 |
|
|
2020
Q4 | $91K | Hold |
1,296
| – | – | 0.06% | 238 |
|
|
2020
Q3 | $90K | Hold |
1,296
| – | – | 0.07% | 224 |
|
|
2020
Q2 | $85K | Buy |
1,296
+119
| +10% | +$7.81K | 0.07% | 226 |
|
|
2020
Q1 | $71K | Buy |
+1,177
| New | +$71K | 0.07% | 195 |
|